SARS-CoV-2MultiTEPIgG,

Tatevik Antonyan1, Garri Chilingaryan1, Karen Zagorski1

  • 1Department of Molecular Immunology, The Institute for Molecular Medicine, Huntington Beach, CA 92647, USA.

PubMed
概括

开发针对SARS-CoV-2等严重急性呼吸道贝塔冠状病毒的通用疫苗至关重要. 这项研究探讨了基于MultiTEP的COVID-19疫苗,这些疫苗产生了抗体,但在小鼠和非人类灵长类动物中缺乏中和活性.